Despite the availability of antiretroviral prophylactic treatment, pediatric human immunodeficiency virus type 1 (HIV-1) continues to be a significant risk factor in the post-cART era. The time of infection (i.e., during pregnancy, delivery or breastfeeding) may play a role in the development of neurocognitive deficits in pediatric HIV-1. HIV-1 viral protein exposure on postnatal day (P)1, preceding the postnatal brain growth spurt in rats, had deleterious effects on neurocognitive development and anatomical parameters of the hippocampus (Fitting et al., 2008a,b). In the present study, rats were stereotaxically injected with HIV-1 viral proteins, including Tat 1-86 and gp120, on P10 to further examine the role of timing on neurocognitive development and anatomical parameters of the hippocampus (Fitting et al., 2010). The dose-dependent virotoxin effects observed across development following P10 Tat 1-86 exposure were specific to spatial learning and absent from prepulse inhibition and locomotor activity. A relationship between alterations in spatial learning and/or memory and hippocampal anatomical parameters was noted. Specifically, the estimated number of neurons and astrocytes in the hilus of the dentate gyrus explained 70% of the variance of search behavior in Morris water maze acquisition training for adolescents and 65% of the variance for adults; a brain-behavior relationship consistent with observations following P1 viral protein exposure. Collectively, late viral protein exposure (P10) results in selective alterations in neurocognitive development without modifying measures of somatic growth, preattentive processing, or locomotor activity, as characterized by early viral protein exposure (P1). Thus, timing may be a critical factor in disease progression, with children infected with HIV earlier in life being more vulnerable to CNS disease.
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Introduction
Pediatric human immunodeficiency virus type 1 (HIV-1) predominantly results from "vertical" mother-to-child transmission (MTCT), occurring during active labor and delivery, pregnancy and/or postnatal breastfeeding (Kourtis et al., 2001; AIDSinfo, 2017) . Marked decreases in the prevalence of pediatric HIV-1 were observed following the implementation of interventions aimed at preventing MTCT, including treatment with combination antiretroviral therapy (cART; Luzuriaga and Mofenson, 2016) . cART is commonly prescribed to HIV-1-infected mothers during pregnancy (Suksomboon et al., 2007; Volmink et al., 2007; Townsend et al., 2008; Briand et al., 2013; Reliquet et al., 2014; Townsend et al., 2014; Wang et al., 2016; Peters et al., 2017) and HIV-1 infected newborns and/or children (Riordan and Bugembe, 2009; Chadwick et al., 2011; van der Plas et al., 2013; Bitnun et al., 2014; Mutwa et al., 2014; Shiau et al., 2017) . Nevertheless, despite the availability of antiretroviral prophylactic treatment, vertical MTCT continues to be a significant risk factor in the post-cART era, with approximately 160,000 children being newly infected in 2016, most of whom live in resource-limited settings (UNAIDS, 2017) .
Additionally, the advent of cART shifted the global epidemic into a new phase as HIV-1 seropositive children survive into adulthood (Sohn and Hazra, 2013; Crowell et al., 2014; Smith and Wilkins, 2015) . By 2020, it is estimated that approximately 1.94 million children will be living with HIV-1 (Penazzato et al., 2014) . The chronic nature of pediatric HIV-1 in the post-cART era has enormous implications for children's neurocognition and development (Vijayan et al., 2009; Brady et al., 2010; Paramesparan et al., 2010; Sohn and Hazra, 2013; Crowell et al., 2014) . Specifically, high rates of subtle to severe neurocognitive deficits have been reported in HIV-1 infected children on cART that survive to adulthood (Burns et al., 2008; Webb et al., 2009; Paramesparan et al., 2010; Crowell et al., 2014) . The causes of these neurocognitive deficits, despite effective cART, are multifactorial and likely include continued viral replication in the central nervous system (CNS), ongoing neuroinflammation, irreversible CNS injury prior to cART initiation, neurotoxic effects of cART, and socioeconomic and 
